Literature DB >> 11719604

Dysregulation of intestinal mucosal immunity: implications in inflammatory bowel disease.

F S Laroux1, K P Pavlick, R E Wolf, M B Grisham.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11719604     DOI： 10.1152/physiologyonline.2001.16.6.272

Source DB:  PubMed          Journal:  News Physiol Sci        ISSN： 0886-1714


× No keyword cloud information.
  9 in total

Review 1.  Biological therapy in the management of recent-onset Crohn's disease: why, when and how?

Authors:  Mark Löwenberg; Maikel Peppelenbosch; Daniel Hommes
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Biologic therapy for inflammatory bowel disease.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity.

Authors:  Thomas Welte; Samuel S M Zhang; Tian Wang; Zhiyuan Zhang; David G T Hesslein; Zhinan Yin; Arihiro Kano; Yoshiki Iwamoto; En Li; Joseph E Craft; Alfred L M Bothwell; Erol Fikrig; Pandelakis A Koni; Richard A Flavell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 4.  Applications of proteomics in the study of inflammatory bowel diseases: Current status and future directions with available technologies.

Authors:  Philip Alex; Marjan Gucek; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

Review 5.  Infliximab therapy in children and adolescents with inflammatory bowel disease.

Authors:  Gabor Veres; Robert N Baldassano; Petar Mamula
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 6.  Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation.

Authors:  Jennifer C Brazil; Charles A Parkos
Journal:  Mucosal Immunol       Date:  2021-11-15       Impact factor: 8.701

7.  Biologic targeting in the treatment of inflammatory bowel diseases.

Authors:  Matteo Bosani; Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Biologics       Date:  2009-07-13

8.  Neutrophil interactions with epithelial-expressed ICAM-1 enhances intestinal mucosal wound healing.

Authors:  R Sumagin; J C Brazil; P Nava; H Nishio; A Alam; A C Luissint; D A Weber; A S Neish; A Nusrat; C A Parkos
Journal:  Mucosal Immunol       Date:  2016-01-06       Impact factor: 7.313

9.  Splenic CD11c(low)CD45RB(high) dendritic cells derived from endotoxin-tolerant mice attenuate experimental acute liver failure.

Authors:  Sai-Nan Zhang; Nai-Bin Yang; Shun-Lan Ni; Jin-Zhong Dong; Chun-Wei Shi; Shan-Shan Li; Sheng-Guo Zhang; Xin-Yue Tang; Ming-Qin Lu
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.